Literature DB >> 15668902

Transformation of hairy cell leukemia to high-grade lymphoma: a case report and review of the literature.

Tsieh Sun1, Nichon Grupka, Catherine Klein.   

Abstract

The coexistence of hairy cell leukemia (HCL) and non-Hodgkin's lymphoma is extremely rare. In the few reports demonstrating such coexistence, the relationship between the 2 entities was mostly inconclusive. We report a case of HCL that transformed to large cell lymphoma. This case has been followed for more than 4 years with immunohistochemical, flow cytometric, and molecular genetic studies on multiple bone marrow biopsy specimens, a splenectomy specimen, and a lymph node biopsy. In our case, the immunophenotype and tartrate-resistant acid phosphatase stain confirmed that the large cell lymphoma was of HCL origin. The markedly increased Ki-67 staining (proliferation fraction) in the lymph node biopsy specimen compared to the earlier splenectomy specimen indicated the transformation of a low-grade leukemia to a high-grade lymphoma. The overexpression of p53 in the lymph node implies that p53 mutation was probably involved in the pathogenesis of HCL transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15668902     DOI: 10.1016/j.humpath.2004.08.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia.

Authors:  Zsófia F Nagy; Kata Ferenczi; Ildikó Istenes; Hanna Eid; Csaba Bödör; Botond Timár; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2022-04-29       Impact factor: 2.874

Review 2.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

3.  Synchronous or Metachronous Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: A Case Series and Literature Review.

Authors:  Vivek Verma; Smith Giri; Vijaya Raj Bhatt; Catalina Amador-Ortiz; James O Armitage
Journal:  Front Oncol       Date:  2017-01-09       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.